Label: GUAIFENESIN tablet, extended release

  • NDC Code(s): 62207-839-72, 62207-840-71, 62207-840-93, 62207-840-99
  • Packager: Granules India Ltd
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated September 30, 2024

If you are a consumer or patient please visit this version.

View All Sections
  • Active ingredients ​(in each extended-release tablet)

    Guaifenesin 600 mg (for 600 mg)

    Guaifenesin 1200 mg (for 1200 mg)

  • purpose

    Expectorant

  • Uses

    • helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive
  • Warnings

    Do not use

    • for children under 12 years of age
  • Ask a doctor before use if you have

    • persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema
    • cough accompanied by too much phlegm (mucus)
  • Stop use and ask a doctor if

    • cough lasts more than 7 days, comes back, or occurs with fever, rash, or persistent headache. These could be signs of a serious illness.
  • If pregnant or breast-feeding,

    ask a health professional before use.

  • Keep out of reach of children

    In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222)

  • Directions

    • do not crush, chew, or break extended-release tablet
    • take with a full glass of water
    • this product can be administered without regard for timing of meals
    • adults and children 12 years of age and over: 1 or 2 extended-release tablets every 12 hours. Do not exceed 4 extended-release tablets in 24 hours (For 600 mg)
    • adults and children 12 years of age and over: 1 extended-release tablet every 12 hours. Do not exceed 2 extended-release tablets in 24 hours. (For 1200 mg)
    • children under 12 years of age: do not use
  • Other information

    • Tamper evident: Do not use if carton is open or if printed seal on blister is broken or missing.
    • store between 20-25°C (68-77°F)
  • Inactive ingredients

    carbomer homopolymer type B; hypromellose; magnesium stearate; microcrystalline cellulose; sodium starch glycolate

  • Questions?

    Contact 1-877-770-3183

    Mon-Fri 8:00 AM EST to 5:00 PM PST.

  • PRINCIPAL DISPLAY PANEL - 600 mg Blister Carton Label

    NDC 62207- 839-72 Compare to the active ingredient
    of Mucinex ®

    Guaifenesin
    Extended-Release Tablets 600 mg

    Guaifenesin 600 mg - Expectorant

    RELIEVES CHEST CONGESTION

    12HR FOR DAY • Relieves Chest Congestion
    OR NIGHT • Thins and Loosens Mucus
    • Immediate and Extended Release

    90 (9 x 10) EXTENDED-RELEASE TABLETS

    guaifenesin-600mg-carton

  • PRINCIPAL DISPLAY PANEL - 1200 mg Blister Carton Label

    NDC 62207- 840-71 Compare to the active ingredient
    of Mucinex®

    Guaifenesin
    Extended-Release Tablets 1200 mg

    Maximum strength

    Guaifenesin 1200 mg - Expectorant


    RELIEVES CHEST CONGESTION

    12HR FOR DAY • Relieves Chest Congestion
    OR NIGHT • Thins and Loosens Mucus
    • Immediate and Extended Release

    70 (7 x 10) EXTENDED-RELEASE TABLETS

    guaifenesin-1200mg-carton

  • PRINCIPAL DISPLAY PANEL

    guaifenesin-label3-jpg

    1200-mg-bulk-label

  • INGREDIENTS AND APPEARANCE
    GUAIFENESIN 
    guaifenesin tablet, extended release
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:62207-839
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    GUAIFENESIN (UNII: 495W7451VQ) (GUAIFENESIN - UNII:495W7451VQ) GUAIFENESIN600 mg
    Inactive Ingredients
    Ingredient NameStrength
    CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED) (UNII: Z135WT9208)  
    HYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4)  
    SODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
    HYPROMELLOSE 2910 (10000 MPA.S) (UNII: 0HO1H52958)  
    Product Characteristics
    ColorwhiteScoreno score
    ShapeOVALSize16mm
    FlavorImprint Code G;600
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:62207-839-729 in 1 CARTON12/18/2020
    110 in 1 BLISTER PACK; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA21342012/18/2020
    GUAIFENESIN 
    guaifenesin tablet, extended release
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:62207-840
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    GUAIFENESIN (UNII: 495W7451VQ) (GUAIFENESIN - UNII:495W7451VQ) GUAIFENESIN1200 mg
    Inactive Ingredients
    Ingredient NameStrength
    HYPROMELLOSE 2910 (10000 MPA.S) (UNII: 0HO1H52958)  
    CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED) (UNII: Z135WT9208)  
    HYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4)  
    SODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
    Product Characteristics
    ColorwhiteScoreno score
    ShapeOVAL (Elliptical) Size22mm
    FlavorImprint Code G;1200
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:62207-840-717 in 1 CARTON12/18/2020
    110 in 1 BLISTER PACK; Type 0: Not a Combination Product
    2NDC:62207-840-994200 in 1 BAG; Type 0: Not a Combination Product12/18/2020
    3NDC:62207-840-9310000 in 1 BOX; Type 0: Not a Combination Product10/31/2022
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA21342012/18/2020
    Labeler - Granules India Ltd (915000087)
    Establishment
    NameAddressID/FEIBusiness Operations
    Ganules India Limited918609236analysis(62207-839, 62207-840) , label(62207-839, 62207-840) , manufacture(62207-839, 62207-840) , pack(62207-839, 62207-840)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!